News Article
Oct 8, 2018
ReViral at 11th International Respiratory Syncytial Virus Symposium

ReViral's CEO, Dr Eddy Littler, and Head of Virology, Dr Elaine Thomas, will be presenting "Low rate of resistance to the RSV fusion inhibitor RV521 in human infection" at the 11th International Respiratory Syncytial Virus Symposium in Asheville, NC, USA (31st Oct - 4th Nov 2018).